LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 25,584 Value ($000) $23 Avg Close $0.93 Range $0.77 - $1.15
Q2 2024
Shares 146,191 Value ($000) $146 Avg Close $1.10 Range $0.84 - $1.56
Q1 2024
Shares 186,627 Value ($000) $276 Avg Close $1.13 Range $0.84 - $1.61
Q3 2023
Shares 51,220 Value ($000) $60 Avg Close $1.36 Range $1.15 - $1.54
Q2 2023
Shares 122,681 Value ($000) $173 Avg Close $1.38 Range $1.24 - $1.57
Q2 2022
Shares 10,886 Value ($000) $17 Avg Close $1.32 Range $1.10 - $1.64
Q1 2022
Shares 55,471 Value ($000) $85 Avg Close $1.55 Range $1.18 - $2.58
Q4 2021
Shares 254,817 Value ($000) $624 Avg Close $2.34 Range $1.80 - $2.71
Q3 2021
Shares 187,486 Value ($000) $472 Avg Close $2.57 Range $2.26 - $2.90
Q2 2021
Shares 25,219 Value ($000) $72 Avg Close $2.59 Range $2.14 - $3.00
Q3 2019
Shares 10,354 Value ($000) $10 Avg Close $1.03 Range $0.82 - $1.26